Epidemiology of infant meningococcal disease in the United States, 2006-2012

Pediatrics

Volumn 135, Issue 2, 2015, Pages e305-e311

  MacNeil, Jessica R ^a   Bennett, Nancy ^b   Farley, Monica M ^c   Harrison, Lee H ^d   Lynfield, Ruth ^e   Nichols, Megin ^f   Petit, Sue ^g   Reingold, Arthur ^h   Schaffner, William ⁱ   Thomas, Ann ^j   Pondo, Tracy ^a   Mayer, Leonard W ^a   Clark, Thomas A ^a   Cohn, Amanda C ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e MINNESOTA DEPARTMENT OF HEALTH   (United States)

^f NEW MEXICO DEPARTMENT OF HEALTH   (United States)

^g CDC   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j OREGON DEPARTMENT OF HUMAN SERVICES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE;

AGE DISTRIBUTION; ARTICLE; BACTERIUM CULTURE; BIRTH WEIGHT; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; GEOGRAPHIC DISTRIBUTION; GESTATIONAL AGE; HOUSEHOLD; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PATHOGEN LOAD; REAL TIME POLYMERASE CHAIN REACTION; SOCIOECONOMICS; UNITED STATES; HEALTH SURVEY; MENINGITIS, MENINGOCOCCAL; MICROBIOLOGY; PATHOGENICITY; SURVIVAL RATE; VIRULENCE;

FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP B; NEISSERIA MENINGITIDIS, SEROGROUP Y; POPULATION SURVEILLANCE; SURVIVAL RATE; UNITED STATES; VIRULENCE;

EID: 84922660428     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-2035     Document Type: Article

References (27)

1. Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis. 2010;50(2):184-191
2. Cohn AC, MacNeil JR, Clark TA, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(RR-2):1-28
3. Report ABCS. Emerging Infections Program Network, Neisseria meningitidis, 2012. Centers for Disease Control and Prevention; 2013. Available at: www.cdc.gov/abcs/reports-findings/survreports/mening12.html. Accessed November 20, 2014
4. Thigpen MC, Whitney CG, Messonnier NE, et al; Emerging Infections Programs Network. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016-2025
5. Schuchat A, Robinson K, Wenger JD, et al; Active Surveillance Team. Bacterial meningitis in the United States in 1995. N Engl J Med. 1997;337(14):970-976
6. Schuchat A, Hilger T, Zell E, et al; Active Bacterial Core Surveillance Team of the Emerging Infections Program Network. Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis. 2001;7(1):92-99
7. Mothershed EA, Sacchi CT, Whitney AM, et al. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identifi cation of Neisseria meningitidis. J Clin Microbiol. 2004;42(1):320-328
8. Raghunathan TELJ, Van Hoewyk J, Solenberger P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol. 2001;27(1):85-95
9. Diermayer M, Hedberg K, Hoesly F, et al. Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain. JAMA. 1999;281(16):1493-1497
10. Centers for Disease Control and Prevention (CDC). Serogroup B meningococcal disease - Oregon, 1994. MMWR Morb Mortal Wkly Rep. 1995;44(7):121-124
11. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med. 1997;16(7):791-801
12. Meningococcal vaccines: WHO position paper, November 2011. Wkly Epidemiol Rec. 2011;86(47):521-539
13. Cartwright KA, Jones DM, Smith AJ, Stuart JM, Kaczmarski EB, Palmer SR. Influenza A and meningococcal disease. Lancet. 1991;338(8766):554-557
14. Fischer M, Hedberg K, Cardosi P, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J. 1997;16(10):979-983
15. Moore PS, Harrison LH, Telzak EE, Ajello GW, Broome CV. Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA. 1988;260(18):2686-2689
16. Stanwell-Smith RE, Stuart JM, Hughes AO, Robinson P, Griffin MB, Cartwright K. Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect. 1994;112(2):315-328
17. Stephens DS, Hajjeh RA, Baughman WS, Harvey RC, Wenger JD, Farley MM. Sporadic meningococcal disease in adults: results of a 5-year population-based study. Ann Intern Med. 1995;123(12):937-940
18. Stuart JM, Cartwright KA, Dawson JA, Rickard J, Noah ND. Risk factors for meningococcal disease: a case control study in south west England. Community Med. 1988;10(2):139-146
19. Yusuf HR, Rochat RW, Baughman WS, et al. Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996. Am J Public Health. 1999;89(5):712-717
20. Murray RL, Britton J, Leonardi-Bee J. Second hand smoke exposure and the risk of invasive meningococcal disease in children: systematic review and meta-analysis. BMC Public Health. 2012;12:1062
21. Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and metaanalysis. Lancet Infect Dis. 2010;10(12):853-861
22. Schuster MA, Franke T, Pham CB. Smoking patterns of household members and visitors in homes with children in the United States. Arch Pediatr Adolesc Med. 2002;156(11):1094-1100
23. Mathews TJ, Hamilton BE. Delayed childbearing: more women are having their first child later in life. NCHS Databrief. 2009. Available at: www.cdc.gov/nchs/data/databriefs/db21.htm. Accessed May 14, 2013
24. Jackson LA, Wenger JD. Laboratorybased surveillance for meningococcal disease in selected areas, United States, 1989-1991. MMWR CDC Surveill Summ. 1993;42(2):21-30
25. Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis. 1999;180(6):1894-1901
26. Caugant DA, Høiby EA, Magnus P, et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol. 1994;32(2):323-330
27. Centers for Disease Control and Prevention (CDC). Infant meningococcal vaccination: Advisory Committee on Immunization Practices (ACIP) recommendations and rationale. MMWR Morb Mortal Wkly Rep. 2013;62(3):52-54